JP2018536714A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018536714A5 JP2018536714A5 JP2018546763A JP2018546763A JP2018536714A5 JP 2018536714 A5 JP2018536714 A5 JP 2018536714A5 JP 2018546763 A JP2018546763 A JP 2018546763A JP 2018546763 A JP2018546763 A JP 2018546763A JP 2018536714 A5 JP2018536714 A5 JP 2018536714A5
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- group
- pharmaceutical composition
- phosphinoyl
- propionylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 150000001875 compounds Chemical class 0.000 claims 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 6
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 3
- -1 acryloxy Chemical group 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 229930195734 saturated hydrocarbon Natural products 0.000 claims 3
- 239000011593 sulfur Chemical group 0.000 claims 3
- 229910052717 sulfur Chemical group 0.000 claims 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims 2
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 claims 2
- 229920000858 Cyclodextrin Polymers 0.000 claims 2
- 206010015958 Eye pain Diseases 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims 2
- 229910052794 bromium Inorganic materials 0.000 claims 2
- 229910052731 fluorine Inorganic materials 0.000 claims 2
- 239000011737 fluorine Substances 0.000 claims 2
- 125000005843 halogen group Chemical group 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229920006395 saturated elastomer Polymers 0.000 claims 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 claims 2
- KEZOVSDHSZHSOM-UHFFFAOYSA-N 1-[1-(2-methylpropanoyloxy)ethoxycarbonylamino]ethyl-[3-oxo-3-[(1-oxo-1-phenylmethoxypropan-2-yl)amino]-2-[(4-phenylphenyl)methyl]propyl]phosphinic acid Chemical compound C=1C=CC=CC=1COC(=O)C(C)NC(=O)C(CP(O)(=O)C(C)NC(=O)OC(C)OC(=O)C(C)C)CC(C=C1)=CC=C1C1=CC=CC=C1 KEZOVSDHSZHSOM-UHFFFAOYSA-N 0.000 claims 1
- DBHIEVDTXYZXEG-UHFFFAOYSA-N 1-aminoethyl-[2-[(4-bromophenyl)methyl]-3-oxo-3-[(1-oxo-1-phenylmethoxypropan-2-yl)amino]propyl]phosphinic acid Chemical compound C(C1=CC=CC=C1)OC(C(C)NC(C(CP(=O)(C(C)N)O)CC1=CC=C(C=C1)Br)=O)=O DBHIEVDTXYZXEG-UHFFFAOYSA-N 0.000 claims 1
- NHFOJXYRWFXHHZ-UHFFFAOYSA-N 1-aminoethyl-[3-oxo-3-[(1-oxo-1-phenylmethoxypropan-2-yl)amino]-2-[(4-phenylphenyl)methyl]propyl]phosphinic acid Chemical compound C=1C=CC=CC=1COC(=O)C(C)NC(=O)C(CP(O)(=O)C(N)C)CC(C=C1)=CC=C1C1=CC=CC=C1 NHFOJXYRWFXHHZ-UHFFFAOYSA-N 0.000 claims 1
- IFTBAMQPMPLZOL-UHFFFAOYSA-N 2-[[2-[(4-bromophenyl)methyl]-3-[hydroxy-[1-[1-(2-methylpropanoyloxy)ethoxycarbonylamino]ethyl]phosphoryl]propanoyl]amino]propanoic acid Chemical compound CC(C)C(=O)OC(C)OC(=O)NC(C)P(O)(=O)CC(C(=O)NC(C)C(O)=O)CC1=CC=C(Br)C=C1 IFTBAMQPMPLZOL-UHFFFAOYSA-N 0.000 claims 1
- WRVVJFLQCNNQSS-UHFFFAOYSA-N 2-[[2-[[1-azaniumylethyl(hydroxy)phosphoryl]methyl]-3-(4-bromophenyl)propanoyl]amino]propanoate Chemical compound OC(=O)C(C)NC(=O)C(CP(O)(=O)C(N)C)CC1=CC=C(Br)C=C1 WRVVJFLQCNNQSS-UHFFFAOYSA-N 0.000 claims 1
- CWJPVKSBGVPXRD-UHFFFAOYSA-N 2-[[2-[[1-azaniumylethyl(hydroxy)phosphoryl]methyl]-3-(4-phenylphenyl)propanoyl]amino]propanoate Chemical compound C1=CC(CC(CP(O)(=O)C(N)C)C(=O)NC(C)C(O)=O)=CC=C1C1=CC=CC=C1 CWJPVKSBGVPXRD-UHFFFAOYSA-N 0.000 claims 1
- ODSBYECYRZQRIK-UHFFFAOYSA-N 2-[[2-[[hydroxy-[1-[1-(2-methylpropanoyloxy)ethoxycarbonylamino]ethyl]phosphoryl]methyl]-3-(4-phenylphenyl)propanoyl]amino]propanoic acid Chemical compound C1=CC(CC(CP(O)(=O)C(C)NC(=O)OC(C)OC(=O)C(C)C)C(=O)NC(C)C(O)=O)=CC=C1C1=CC=CC=C1 ODSBYECYRZQRIK-UHFFFAOYSA-N 0.000 claims 1
- BDXDIOMYACZVMS-UHFFFAOYSA-N C(C)OC(=O)OOC(C(C)NC(C(CP(=O)(C(C)N)O)CC1=CC=C(C=C1)C1=CC=CC=C1)=O)=O Chemical compound C(C)OC(=O)OOC(C(C)NC(C(CP(=O)(C(C)N)O)CC1=CC=C(C=C1)C1=CC=CC=C1)=O)=O BDXDIOMYACZVMS-UHFFFAOYSA-N 0.000 claims 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- 239000001116 FEMA 4028 Substances 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 208000004454 Hyperalgesia Diseases 0.000 claims 1
- 208000035154 Hyperesthesia Diseases 0.000 claims 1
- 125000000815 N-oxide group Chemical group 0.000 claims 1
- 150000001204 N-oxides Chemical class 0.000 claims 1
- HQHQUKKBWTVSRU-UHFFFAOYSA-N [2-[(4-bromophenyl)methyl]-3-oxo-3-[(1-oxo-1-phenylmethoxypropan-2-yl)amino]propyl]-[1-[1-(2-methylpropanoyloxy)ethoxycarbonylamino]ethyl]phosphinic acid Chemical compound C=1C=CC=CC=1COC(=O)C(C)NC(=O)C(CP(O)(=O)C(C)NC(=O)OC(C)OC(=O)C(C)C)CC1=CC=C(Br)C=C1 HQHQUKKBWTVSRU-UHFFFAOYSA-N 0.000 claims 1
- UOYXBIFDUUCEHF-UHFFFAOYSA-N [3-[(1-ethoxy-1-oxopropan-2-yl)amino]-3-oxo-2-[(4-phenylphenyl)methyl]propyl]-[1-[1-(2-methylpropanoyloxy)ethoxycarbonylamino]ethyl]phosphinic acid Chemical compound C1=CC(CC(C(=O)NC(C)C(=O)OCC)CP(O)(=O)C(C)NC(=O)OC(C)OC(=O)C(C)C)=CC=C1C1=CC=CC=C1 UOYXBIFDUUCEHF-UHFFFAOYSA-N 0.000 claims 1
- WIQWUFMEEZUBRR-UHFFFAOYSA-N [3-[(1-ethoxycarbonylperoxy-1-oxopropan-2-yl)amino]-3-oxo-2-[(4-phenylphenyl)methyl]propyl]-[1-[1-(2-methylpropanoyloxy)ethoxycarbonylamino]ethyl]phosphinic acid Chemical compound C(C)OC(=O)OOC(C(C)NC(C(CP(=O)(C(C)NC(=O)OC(C)OC(C(C)C)=O)O)CC1=CC=C(C=C1)C1=CC=CC=C1)=O)=O WIQWUFMEEZUBRR-UHFFFAOYSA-N 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims 1
- 229960004853 betadex Drugs 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 239000003885 eye ointment Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- RCCPEORTSYDPMB-UHFFFAOYSA-N hydroxy benzenecarboximidothioate Chemical compound OSC(=N)C1=CC=CC=C1 RCCPEORTSYDPMB-UHFFFAOYSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 230000002981 neuropathic effect Effects 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 229940006186 sodium polystyrene sulfonate Drugs 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 229940097346 sulfobutylether-beta-cyclodextrin Drugs 0.000 claims 1
- 125000004434 sulfur atom Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1561598A FR3044227B1 (fr) | 2015-11-30 | 2015-11-30 | Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires |
| FR1561598 | 2015-11-30 | ||
| PCT/EP2016/079285 WO2017093322A1 (fr) | 2015-11-30 | 2016-11-30 | Dérivés aminophosphiniques pour la prévention et le traitement des douleurs oculaires |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018536714A JP2018536714A (ja) | 2018-12-13 |
| JP2018536714A5 true JP2018536714A5 (enExample) | 2020-01-16 |
| JP6889176B2 JP6889176B2 (ja) | 2021-06-18 |
Family
ID=55346018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018546763A Active JP6889176B2 (ja) | 2015-11-30 | 2016-11-30 | 眼痛を予防及び治療するためのアミノホスフィン酸誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20180344753A1 (enExample) |
| EP (1) | EP3383403B1 (enExample) |
| JP (1) | JP6889176B2 (enExample) |
| KR (1) | KR102657652B1 (enExample) |
| CN (2) | CN108289901B (enExample) |
| BR (1) | BR112018010007A2 (enExample) |
| CA (1) | CA3006365A1 (enExample) |
| DK (1) | DK3383403T3 (enExample) |
| ES (1) | ES2773148T3 (enExample) |
| FR (1) | FR3044227B1 (enExample) |
| IL (1) | IL259562B (enExample) |
| MX (1) | MX382921B (enExample) |
| TW (1) | TWI729039B (enExample) |
| WO (1) | WO2017093322A1 (enExample) |
| ZA (1) | ZA201804037B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9993427B2 (en) * | 2013-03-14 | 2018-06-12 | Biorest Ltd. | Liposome formulation and manufacture |
| CN110352060A (zh) * | 2017-03-09 | 2019-10-18 | 领先药物公司 | 用于预防和治疗眼部炎症的氨基次膦酸衍生物 |
| FR3063635B1 (fr) * | 2017-03-09 | 2019-06-07 | Pharmaleads | Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire |
| FR3104581B1 (fr) * | 2019-12-11 | 2021-11-26 | Pharmaleads | Procédé de préparation industrielle du sel disodique de ((2S)-3-([1,1'-biphenyl]-4-yl)-2-((hydroxy((1R)-1-(((1-(isobutyryloxy)ethoxy)carbonyl)amino)ethyl)phosphoryl) methyl)propanoyl)-L-alanine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0987291A (ja) * | 1995-09-26 | 1997-03-31 | Wakamoto Pharmaceut Co Ltd | 新規なアラニン誘導体 |
| FR2755135B1 (fr) | 1996-10-25 | 2002-12-27 | Inst Nat Sante Rech Med | Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent |
| JP2001506652A (ja) * | 1996-12-16 | 2001-05-22 | アルコン ラボラトリーズ，インコーポレイテッド | 眼の痛みを治療するためのκオピオイド・アゴニストの局所使用 |
| FR2777780B1 (fr) * | 1998-04-22 | 2001-05-04 | Inst Nat Sante Rech Med | Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent |
| FR2934267B1 (fr) * | 2008-07-23 | 2010-08-13 | Pharmaleads | Derives aminophosphiniques utiles dans le traitement de la douleur |
| FR2934627B1 (fr) | 2008-07-29 | 2010-08-13 | Paul Marie Bernard | Dispositif de positionnement et de calage d'un garde corps escamotable sur plateforme support de banches |
| AU2014216273A1 (en) * | 2013-02-13 | 2015-07-09 | Novartis Ag | Topical ocular analgesic agents |
-
2015
- 2015-11-30 FR FR1561598A patent/FR3044227B1/fr not_active Expired - Fee Related
-
2016
- 2016-11-30 TW TW105139517A patent/TWI729039B/zh active
- 2016-11-30 KR KR1020187018504A patent/KR102657652B1/ko active Active
- 2016-11-30 WO PCT/EP2016/079285 patent/WO2017093322A1/fr not_active Ceased
- 2016-11-30 EP EP16809676.6A patent/EP3383403B1/fr active Active
- 2016-11-30 BR BR112018010007-2A patent/BR112018010007A2/pt not_active Application Discontinuation
- 2016-11-30 US US15/779,220 patent/US20180344753A1/en not_active Abandoned
- 2016-11-30 DK DK16809676.6T patent/DK3383403T3/da active
- 2016-11-30 CN CN201680070092.8A patent/CN108289901B/zh active Active
- 2016-11-30 CN CN202010893476.8A patent/CN112121008A/zh active Pending
- 2016-11-30 CA CA3006365A patent/CA3006365A1/fr active Pending
- 2016-11-30 MX MX2018006580A patent/MX382921B/es unknown
- 2016-11-30 ES ES16809676T patent/ES2773148T3/es active Active
- 2016-11-30 JP JP2018546763A patent/JP6889176B2/ja active Active
-
2018
- 2018-05-23 IL IL259562A patent/IL259562B/en active IP Right Grant
- 2018-06-15 ZA ZA2018/04037A patent/ZA201804037B/en unknown
-
2019
- 2019-02-11 US US16/272,573 patent/US10688113B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1116513A (en) | Composition containing 1,2-benzisothiazolin-3-one | |
| JP2016536363A5 (enExample) | ||
| JP2016536364A5 (enExample) | ||
| JP2013531029A5 (enExample) | ||
| EA201891191A1 (ru) | 2-замещенные соединения хиназолина, содержащие замещенную гетероциклическую группу, и способы их применения | |
| WO2016097869A4 (en) | Fused ring heteroaryl compounds and their use as trk inhibitors | |
| AR091857A1 (es) | INHIBIDORES DE CISTATIONIN-g-LIASA (CSE) | |
| EA201490407A1 (ru) | Содержащие гидразид модуляторы нуклеарного транспорта и их применения | |
| MX380928B (es) | Inhibidores de kras g12c. | |
| TR201904158T4 (tr) | Osteoartrit tedavisi için adamts inhibitörleri olarak 5-[(piperazin-1-il)-3-okso-propil]-imidazolidin-2,4-dion türevleri. | |
| AR089800A1 (es) | Composiciones herbicidas solidas mejoradas con adyuvante incorporado | |
| TN2015000445A1 (en) | Derivatives of dolastatin 10 and auristatins | |
| WO2010012762A3 (de) | Farbstabiler superabsorber | |
| EA201000619A1 (ru) | Новые производные имидазола | |
| JP2017531677A5 (enExample) | ||
| RU2020115045A (ru) | Азотсодержащее гетероарильное соединение и его фармацевтическое применение | |
| EA201690408A1 (ru) | Производные этинила | |
| AR120578A1 (es) | DERIVADOS DE BENCILAMIDA COMO INHIBIDORES DEL RECEPTOR DEL FACTOR DE CRECIMIENTO TRANSFORMANTE b1 (TGFbRI) / ALK5 | |
| JP2019065009A5 (enExample) | ||
| CN103118973B (zh) | 羟基吡啶酮或其盐用于稳定化过氧化氢或释放过氧化氢的物质的用途 | |
| RU2011100106A (ru) | Замещенные бензимидазолы для лечения нейрофиброматоза | |
| JP2013223715A5 (enExample) | ||
| MY144623A (en) | Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht 1f agonists | |
| JP2011524362A5 (enExample) | ||
| EA200900862A1 (ru) | Производные простациклина |